CG
GOSS icon

Cutler Group’s Gossamer Bio GOSS Stock Holding History

Cutler Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,400
Closed -$1K – 3983
2023
Q2 		$1K Buy
1,400
+500
+56% +$623 ﹤0.01% 3281
2023
Q1 		$1K Sell
900
-4,822
-84% -$9.23K ﹤0.01% 3429
2022
Q4 		$12K Buy
5,722
+3,090
+117% +$25.4K ﹤0.01% 2578
2022
Q3 		$31K Buy
2,632
+2,172
+472% +$27K ﹤0.01% 2272
2022
Q2 		$3K Buy
+460
New +$3.56K ﹤0.01% 4045
2021
Q3 		– Sell
-1,500
Closed -$12K – 5939
2021
Q2 		$12K Buy
+1,500
New +$13K ﹤0.01% 3737
2020
Q4 		– Sell
-2,500
Closed -$31K – 5056
2020
Q3 		$31K Buy
+2,500
New +$33.1K ﹤0.01% 2131
2020
Q2 		– Sell
-400
Closed -$4K – 4559
2020
Q1 		$4K Sell
400
-900
-69% -$11.8K ﹤0.01% 3183
2019
Q4 		$20K Buy
+1,300
New +$26.2K ﹤0.01% 2209

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Cutler Group's GOSS Position: Q3 2023 in Review

Cutler Group sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 1,400 shares — an estimated $1K sold.

Cutler Group first reported a position in GOSS in Q4 2019 and held it in 9 quarters. The position peaked at $31K in Q3 2022. 95 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Cutler Group reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 1,400 Gossamer Bio shares in Q3 2023, an estimated $1K.
  • Cutler Group first reported a position in Gossamer Bio in Q4 2019 and held it in 9 quarters.
  • Cutler Group's Gossamer Bio position peaked at $31K in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.